Panel Presentation: Let's Get Back on Track - Perspectives from Brazil, Nigeria, South Africa and Uganda on Achieving 2030 UNAIDS Goals

In this session, researchers, clinicians, and program implementers from four countries will address the disruption in continuity of care for PLHIV amid the COVID-19 pandemic and the consequent implications for drug resistance in individuals on ART. Panelists will highlight their country's progress to 90-90-90 goals pre-pandemic and discuss the current state-of-affairs in reaching the 2030 targets of 95-95-95. Key topics include: lessons learned from COVID-19 and their application to HIV patient monitoring and HIV drug resistance surveillance; opportunities to leverage HIV program structure to expand access to COVID-19 testing and vaccination; and recommended course of action to address gaps in care for PLHIV.
 
Learning Objectives:

1. Analyze the impact of COVID-19 pandemic on UNAIDs goals.

2. Discuss disruption in ART adherence and impact on emerging ART drug resistance mutations.

3. Assess the state of HIV drug resistance for surveillance and patient management.

4. Explain how to apply best practices gained from responding to COVID-19 on HIV patient monitoring and epidemiologic and genetic surveillance.